《新股消息》海納智能裝備(01645.HK)今日起招股 入場費6,060元
內地衛生用品機器製造商海納智能裝備(01645.HK)公布招股詳情,計劃發售1.16億股股份,當中10%為本港公開發售,90%為國際配售。每股招股價介乎1.08元至1.5元,集資最多1.74億元。每手4,000股,入場費6,060.46元,由今日(20日)起至下周一(25日)公開招股,預計於6月3日掛牌。建泉融資為獨家保薦人。
以招股價中位數1.29元計,公司估計集資淨額為1.13億元,當中23.2%用作於中國晉江市設立新研究中心;約22.2%將用作提升研發實力;約16.2%用作增強產能;35.1%將用作收購提升競爭力;以及3.3%用於營運資金及一般企業用途。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.